Supplementary Methods and Materials from Breast Cancer Expressing the Activated HER2/neu Is Sensitive to Gefitinib <i>In vitro</i> and <i>In vivo</i> and Acquires Resistance through a Novel Point Mutation in the HER2/neu

Marie P. Piechocki,George H. Yoo, Susan K. Dibbley,Fulvio Lonardo

crossref（2023）

引用 0|浏览0

暂无评分

摘要

Supplementary Methods and Materials from Breast Cancer Expressing the Activated HER2/neu Is Sensitive to Gefitinib In vitro and In vivo and Acquires Resistance through a Novel Point Mutation in the HER2/neu

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Supplementary Methods and Materials from Breast Cancer Expressing the Activated HER2/neu Is Sensitive to Gefitinib &lt;i&gt;In vitro&lt;/i&gt; and &lt;i&gt;In vivo&lt;/i&gt; and Acquires Resistance through a Novel Point Mutation in the HER2/neu

Supplementary Methods and Materials from Breast Cancer Expressing the Activated HER2/neu Is Sensitive to Gefitinib <i>In vitro</i> and <i>In vivo</i> and Acquires Resistance through a Novel Point Mutation in the HER2/neu